Congress can support pediatric cancer patients by passing the Mikaela Naylon Give Kids a Chance Act

Last week the House of Representatives unanimously passed the Mikaela Naylon Give Kids a Chance Act. This legislation will  give the FDA authority to direct pediatric cancer trials for combination drugs, reauthorize the Rare Pediatric Priority Review Voucher, and provide more funds for NIH pediatric drug studies. This legislation is an important step forward in the fight to close gaps in pediatric cancer research and develop more effective, less toxic medicine.  We applaud the bill’s sponsors and all of the advocates who fought so hard to make this happen. We strongly urge the Senate to pass the Mikaela Naylon Give Kids a Chance Act and send this bill to the President to be signed into law.

More information about the Mikaela Naylon Give Kids a Chance Act can be found HERE.

Contact your Senators and urge them to vote YES on the Mikaela Naylon Give Kids a Chance Act. You can find your Senators HERE.